These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15190064)

  • 21. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
    Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
    Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
    Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.
    Hamada S; Nishida Y; Zhuo L; Shinomura T; Ikuta K; Arai E; Koike H; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2018 Jun; 36(6):1573-1580. PubMed ID: 29091320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation.
    Chao H; Spicer AP
    J Biol Chem; 2005 Jul; 280(30):27513-22. PubMed ID: 15843373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of Thr
    Kasai K; Kuroda Y; Takabuchi Y; Nitta A; Kobayashi T; Nozaka H; Miura T; Nakamura T
    Biochem Biophys Res Commun; 2020 Dec; 533(4):732-738. PubMed ID: 32993960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of small proteoglycan synthesis by the hyaluronan synthesis inhibitor 4-methylumbelliferone in human skin fibroblasts.
    Funahashi M; Nakamura T; Kakizaki I; Mizunuma H; Endo M
    Connect Tissue Res; 2009; 50(3):194-202. PubMed ID: 19444760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
    Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
    Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.
    Arai E; Nishida Y; Wasa J; Urakawa H; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Br J Cancer; 2011 Dec; 105(12):1839-49. PubMed ID: 22045192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
    Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
    Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
    Galgoczi E; Jeney F; Katko M; Erdei A; Gazdag A; Sira L; Bodor M; Berta E; Ujhelyi B; Steiber Z; Gyory F; Nagy EV
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):27. PubMed ID: 32084270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors.
    Edward M; Quinn JA; Pasonen-Seppänen SM; McCann BA; Tammi RH
    Br J Dermatol; 2010 Jun; 162(6):1224-32. PubMed ID: 20163414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines.
    Jokela TA; Jauhiainen M; Auriola S; Kauhanen M; Tiihonen R; Tammi MI; Tammi RH
    J Biol Chem; 2008 Mar; 283(12):7666-73. PubMed ID: 18201970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.
    Nair PC; Chau N; McKinnon RA; Miners JO
    Mol Pharmacol; 2020 Dec; 98(6):710-718. PubMed ID: 33008919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effects of hyaluronan inhibition in desmoid tumors.
    Briggs A; Rosenberg L; Buie JD; Rizvi H; Bertagnolli MM; Cho NL
    Carcinogenesis; 2015 Feb; 36(2):272-9. PubMed ID: 25556151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hyaluronan synthesis reduces versican and fibronectin levels in trabecular meshwork cells.
    Keller KE; Sun YY; Vranka JA; Hayashi L; Acott TS
    PLoS One; 2012; 7(11):e48523. PubMed ID: 23139787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronan biosynthesis by class I streptococcal hyaluronan synthases occurs at the reducing end.
    Tlapak-Simmons VL; Baron CA; Gotschall R; Haque D; Canfield WM; Weigel PH
    J Biol Chem; 2005 Apr; 280(13):13012-8. PubMed ID: 15668242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hyaluronic acid formation sensitizes chronic myelogenous leukemia to treatment with doxorubicin.
    Uchakina ON; Ban H; Hostetler BJ; McKallip RJ
    Glycobiology; 2016 Nov; 26(11):1171-1179. PubMed ID: 27261196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.